Literature DB >> 33860373

Photoreceptor phosphodiesterase (PDE6): activation and inactivation mechanisms during visual transduction in rods and cones.

Rick H Cote1.   

Abstract

Rod and cone photoreceptors of the vertebrate retina utilize cGMP as the primary intracellular messenger for the visual signaling pathway that converts a light stimulus into an electrical response. cGMP metabolism in the signal-transducing photoreceptor outer segment reflects the balance of cGMP synthesis (catalyzed by guanylyl cyclase) and degradation (catalyzed by the photoreceptor phosphodiesterase, PDE6). Upon light stimulation, rapid activation of PDE6 by the heterotrimeric G-protein (transducin) triggers a dramatic drop in cGMP levels that lead to cell hyperpolarization. Following cessation of the light stimulus, the lifetime of activated PDE6 is also precisely regulated by additional processes. This review summarizes recent advances in the structural characterization of the rod and cone PDE6 catalytic and regulatory subunits in the context of previous biochemical studies of the enzymological properties and allosteric regulation of PDE6. Emphasis is given to recent advances in understanding the structural and conformational changes underlying the mechanism by which the activated transducin α-subunit binds to-and relieves inhibition of-PDE6 catalysis that is controlled by its intrinsically disordered, inhibitory γ-subunit. The role of the regulator of G-protein signaling 9-1 (RGS9-1) in regulating the lifetime of the transducin-PDE6 is also briefly covered. The therapeutic potential of pharmacological compounds acting as inhibitors or activators targeting PDE6 is discussed in the context of inherited retinal diseases resulting from mutations in rod and cone PDE6 genes as well as other inherited defects that arise from excessive cGMP accumulation in retinal photoreceptor cells.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Cone photoreceptor; Cyclic GMP; Phosphodiesterase; Photoreceptor; Retina; Retinal disease; Review; Rod photoreceptor; Visual excitation; Visual transduction

Mesh:

Substances:

Year:  2021        PMID: 33860373      PMCID: PMC8376765          DOI: 10.1007/s00424-021-02562-x

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   4.458


  147 in total

1.  Specific binding of RGS9-Gbeta 5L to protein anchor in photoreceptor membranes greatly enhances its catalytic activity.

Authors:  Polina V Lishko; Kirill A Martemyanov; Johnathan A Hopp; Vadim Y Arshavsky
Journal:  J Biol Chem       Date:  2002-05-02       Impact factor: 5.157

2.  Intrinsically disordered gamma-subunit of cGMP phosphodiesterase encodes functionally relevant transient secondary and tertiary structure.

Authors:  Jikui Song; Lian-Wang Guo; Hakim Muradov; Nikolai O Artemyev; Arnold E Ruoho; John L Markley
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-29       Impact factor: 11.205

3.  Domain organization and conformational plasticity of the G protein effector, PDE6.

Authors:  Zhixian Zhang; Feng He; Ryan Constantine; Matthew L Baker; Wolfgang Baehr; Michael F Schmid; Theodore G Wensel; Melina A Agosto
Journal:  J Biol Chem       Date:  2015-03-25       Impact factor: 5.157

4.  Elementary response triggered by transducin in retinal rods.

Authors:  Wendy W S Yue; Daniel Silverman; Xiaozhi Ren; Rikard Frederiksen; Kazumi Sakai; Takahiro Yamashita; Yoshinori Shichida; M Carter Cornwall; Jeannie Chen; King-Wai Yau
Journal:  Proc Natl Acad Sci U S A       Date:  2019-02-22       Impact factor: 11.205

5.  Phosphodiesterase 6 subunits are expressed and altered in idiopathic pulmonary fibrosis.

Authors:  Sevdalina Nikolova; Andreas Guenther; Rajkumar Savai; Norbert Weissmann; Hossein A Ghofrani; Melanie Konigshoff; Oliver Eickelberg; Walter Klepetko; Robert Voswinckel; Werner Seeger; Friedrich Grimminger; Ralph T Schermuly; Soni S Pullamsetti
Journal:  Respir Res       Date:  2010-10-27

6.  Reciprocal effects of an inhibitory factor on catalytic activity and noncatalytic cGMP binding sites of rod phosphodiesterase.

Authors:  A Yamazaki; F Bartucca; A Ting; M W Bitensky
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

7.  Structure of the Visual Signaling Complex between Transducin and Phosphodiesterase 6.

Authors:  Yang Gao; Gözde Eskici; Sekar Ramachandran; Frédéric Poitevin; Alpay Burak Seven; Ouliana Panova; Georgios Skiniotis; Richard A Cerione
Journal:  Mol Cell       Date:  2020-10-01       Impact factor: 17.970

8.  Aryl Hydrocarbon Receptor-interacting Protein-like 1 Is an Obligate Chaperone of Phosphodiesterase 6 and Is Assisted by the γ-Subunit of Its Client.

Authors:  Kota N Gopalakrishna; Kimberly Boyd; Ravi P Yadav; Nikolai O Artemyev
Journal:  J Biol Chem       Date:  2016-06-07       Impact factor: 5.157

Review 9.  Therapeutic targeting of 3',5'-cyclic nucleotide phosphodiesterases: inhibition and beyond.

Authors:  George S Baillie; Gonzalo S Tejeda; Michy P Kelly
Journal:  Nat Rev Drug Discov       Date:  2019-08-06       Impact factor: 84.694

10.  Conformation changes, N-terminal involvement, and cGMP signal relay in the phosphodiesterase-5 GAF domain.

Authors:  Huanchen Wang; Howard Robinson; Hengming Ke
Journal:  J Biol Chem       Date:  2010-09-21       Impact factor: 5.157

View more
  3 in total

1.  Reproducibility of the Rod Photoreceptor Response Depends Critically on the Concentration of the Phosphodiesterase Effector Enzyme.

Authors:  Ala Morshedian; Gabriela Sendek; Sze Yin Ng; Kimberly Boyd; Roxana A Radu; Mingyao Liu; Nikolai O Artemyev; Alapakkam P Sampath; Gordon L Fain
Journal:  J Neurosci       Date:  2022-01-28       Impact factor: 6.709

Review 2.  The Role of Hsp90 in Retinal Proteostasis and Disease.

Authors:  Kalliopi Ziaka; Jacqueline van der Spuy
Journal:  Biomolecules       Date:  2022-07-12

3.  Where vision begins.

Authors:  Daniele Dell'Orco; Karl-Wilhelm Koch; Giorgio Rispoli
Journal:  Pflugers Arch       Date:  2021-09       Impact factor: 4.458

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.